NZ Study: Pfizer’s mRNA Vaccine Statistically Significant Link to Myocarditis

New Zealand Study: Pfizer’s mRNA Vaccine Statistically Significant Link to Myocarditis (https://youtube.com/watch?v=QAaTxU8Eg_o)
Join The Conversation! | https://trialsitenews.com/

Researchers from the New Zealand Ministry of Health as well as University of Auckland conducted a real-world observational study probing rates of adverse events of special interest (AESIs) associated with a primary dose of the Pfizer-BioNTech mRNA COVID-19 vaccine, BNT162b2, in the New Zealand population aged 5 years and up vaccinated from 19 February 2021, to 10 February 2022.

Tapping into electronic health records, the Kiwi investigators looked for risk within the period of day 0 to 21 days after the jab compared with expected rates based on background health data from 2014 to 2019.